Results 21 to 30 of about 3,120,599 (339)

Focus : Dispositif expérimentaux pare-congères du Puy-de-Dôme [PDF]

Sciences, Eaux & Territoires, 2010
Le conseil général du Puy-de-Dôme est confronté chaque année à la formation de congères, impliquant des dépenses conséquentes pour assurer la viabilité de ses routes départementales.
NAAIM-BOUVET, Florence, MONIER, Sylvie, MONIER, Sylvie   +2 more
doaj  

The realities and aspirations of people experiencing food insecurity in Tāmaki Makaurau

Kōtuitui, 2022
Given the strong links between food security and wellbeing, addressing the increasing lack of access to adequate, appropriate food is necessary to realise the current Aotearoa New Zealand government’s wellbeing-related ambitions.
Caitlin Neuwelt-Kearns, Alice Nicholls, Kelsey L. Deane, Helen Robinson, Desiree Lowe, Ra Pope, Tracy Goddard, Micaela van der Schaaf, Allen Bartley   +8 more
doaj   +1 more source

Focus : Bande boisée du Col de La Fageole [PDF]

Sciences, Eaux & Territoires, 2010
Au Col de la Fageole, une bande boisée a été mise en place il y a vingt ans pour protéger la route nationale contre la formation de congères. Qu'en-est-il aujourd'hui ?
NAAIM-BOUVET, Florence, MONIER, Sylvie, MONIER, Sylvie   +2 more
doaj  

The LISA pathfinder mission [PDF]

, 2015
ISA Pathfinder (LPF), the second of the European Space Agency's Small Missions for Advanced Research in Technology (SMART), is a dedicated technology validation mission for future spaceborne gravitational wave detectors, such as the proposed eLISA ...
Armano, M, Audley, H, Auger, G, Baird, J, Binetruy, P, Born, M, Bortoluzzi, D, Brandt, N, Bursi, A, Caleno, M, Cavalleri, A, Cesarini, A, Cruise, M, Danzmann, K, Diepholz, I, Dolesi, R, Dunbar, N, Ferraioli, L, Ferroni, V, Fitzsimons, E, Freschi, M, Gallegos, J, Gerndt, R, Gesa, L I, Giardini, D, Gibert, F, Giusteri, R, Grimani, C, Harrison, I, Heinzel, G, Hewitson, M, Hollington, D, Hueller, M, Huesler, J, Inchauspé, H, Jennrich, O, Jetzer, P, Johlander, B, Karnesis, N, Kaune, B, Killow, C., Korsakova, N, Lloro, I, Maarschalkerweerd, R, Madden, S, Mance, D, Marirrodriga, C García, Martin-Porqueras, F, Martín, V, Mateos, I, McNamara, P, Mendes, J, Mendes, L, Moroni, A, Nofrarias, M, Paczkowski, S, Perez, J A Romera, Perreur-Lloyd, M., Petiteau, A, Pivato, P, Plagnol, E, Prat, P, Ragnit, U, Ramos-Castro, J, Reiche, J, Robertson, D., Rozemeijer, H, Russano, G, Sarra, P, Schleicher, A, Slutsky, J, Sopuerta, C F, Sumner, T, Texier, D, Thorpe, J, Trenkel, C, Tu, H B, Vetrugno, D, Vitale, S, Wanner, G, Ward, H., Waschke, S, Wass, P, Wealthy, D, Weber, W, Wen, S, Wittchen, A, Zanoni, C, Ziegler, T, Zweifel, P   +89 more
core   +3 more sources

Percutaneous coronary intervention of anomalous right coronary artery arising from the left sinus of Valsalva with the novel use of Ikari left guide catheter- A case series

IHJ Cardiovascular Case Reports, 2022
Percutaneous coronary intervention for anomalous right coronary artery arising from the left sinus of Valsalva poses technical challenges in cannulation due to its unusual location, non-circular orifice and course. We describe a series of cases here with
Karthikeyan Balakrishnan, MD, DM, Suma M. Victor, DNB, DNB, FNB, Avinash Kumar, BSc, MBA, Vijayakumar Subban, MD, DM, FNB   +3 more
doaj   +1 more source

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Haies et boisements pare-congères : de la théorie à la pratique [PDF]

Sciences, Eaux & Territoires, 2010
Lorsque la neige et le vent s'associent, ils créent des congères qui vont gêner la circulation sur les routes et les chemins de montagne. Pour lutter contre ce problème, l'implantation de haies et de boisements apparait comme une solution écologique et ...
NAAIM-BOUVET, Florence, MONIER, Sylvie, MONIER, Sylvie   +2 more
doaj  

Preparedness, resilience and unmet needs of informal caregivers of advanced cancer patients in a Regional Mission Hospital in Kenya: Qualitative Study

BMC Palliative Care, 2023
Background Cancer is the third highest cause of death in Kenya. Eighty percent of cancer cases arrive at advanced stages, when there is nothing that can be done to cure them, and palliative care is the best alternative.
Wesley Too, Faith Lelei, Mary Adam, Pete Halestrap   +3 more
doaj   +1 more source

Developing evidence‐based, cost‐effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

Molecular Oncology, EarlyView.
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou‐Zeid, Vanderlei Bagnato, Christian Brandts, Chien‐Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking   +43 more
wiley   +1 more source